Stuart McLachlan
Corporate Officer/Principal presso Lypanosys Pte Ltd.
Posizioni attive di Stuart McLachlan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Lypanosys Pte Ltd.
 Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 06/06/2011 | - |
Storia della carriera di Stuart McLachlan
Formazione di Stuart McLachlan
| University of California, Davis | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
| Singapore | 2 |
Posizioni
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Stuart McLachlan
- Esperienza
